Patients with T2DM had statistically significant lower serum Beclin1 compared to control subjects (1.28 ± 0.51 vs 5.24 ± 1.22 ng/dL, respectively; P < .001) (Fig. 1). This evidence concerns the gene BECN1 and type 2 diabetes mellitus.